Phase II trial of N-methylformamide for advanced renal cell carcinoma

Cancer Treat Rep. 1986 May;70(5):681-2.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / secondary
  • Chemical and Drug Induced Liver Injury
  • Drug Evaluation
  • Female
  • Formamides / adverse effects
  • Formamides / therapeutic use*
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Lung Neoplasms / secondary
  • Male
  • Middle Aged
  • Nausea / chemically induced

Substances

  • Antineoplastic Agents
  • Formamides
  • methylformamide